Quick access to main page (top) Direct access to main contents Quick access to main page (bottom)

Weight Loss Drug Semaglutide Could Alleviate Knee Osteoarthritis Pain, Study Shows

Daniel Kim Views  

DB
DB

A recent study suggests that semaglutide, commonly found in GLP-1 medications like Wegovy and Ozempic, may help reduce knee osteoarthritis pain in obese patients. Published in The New England Journal of Medicine, the research highlights a new potential benefit of semaglutide beyond its usual application in managing blood sugar levels and promoting weight loss for type 2 diabetes.

The study, conducted by Novo Nordisk as part of a Phase 3 clinical trial, examined the effects of semaglutide versus placebo on body weight and knee pain in 407 obese patients with an average age of 56 and a BMI of 40.3. Over 68 weeks, participants received weekly doses of either 2.4 mg of semaglutide or a placebo.

Results showed that those taking semaglutide achieved an average weight loss of 13.7%, compared to 3.2% for the placebo group. Researchers also measured pain levels using the WOMAC (Western Ontario and McMaster Universities Osteoarthritis Index) scale, where a higher score indicates more severe pain. Participants on semaglutide reported a decrease in WOMAC scores from an average of 70.9 to 41.7, while the placebo group saw only a 27.5-point drop.

The study concludes that semaglutide could offer pain relief benefits for knee osteoarthritis in obese patients, suggesting a promising therapeutic potential for this medication in managing osteoarthritis symptoms.

Daniel Kim
content@viewusglobal.com

Comments0

300

Comments0

[LIFESTYLE] Latest Stories

  • How Vitamin D Could Help Lower Colon Cancer Risk
  • Yes, IVF Can Cause Weight Gain — Here's Why You Shouldn't Panic
  • Red Jewels for Your Health: 7 Amazing Benefits of Pomegranates
  • Hidden Danger: 5 'Healthy Foods' That Can Worsen Gout
  • Spring’s Secret Weapon for Dry Coughs: Meet Liriope Tea
  • FDA Approves $3.1M Gene Therapy for Rare, Painful Skin Disorder

Share it on...